TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32690523

Group type: EXPERIMENTAL
Intervention: Almond-enriched diet (AED) (15% energy from almonds)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Nut-free control diet (NFD) (15% energy from carbohydrate-rich snack foods)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Almond-enriched diet (AED)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Nut-free control diet (NFD)
Number of subjects: 134
Study: 35398908

Group type: EXPERIMENTAL
Intervention: Biofeedback
Number of subjects: 20

Group type: COMPARATOR
Intervention: Music-only condition (sham treatment)
Number of subjects: 20
Study: 33442031

Group type: EXPERIMENTAL
Intervention: Home blood pressure monitoring (HBPM)
Number of subjects: 501
Study: 32925739

Group type: EXPERIMENTAL
Intervention: MRI-targeted biopsy (TBx) alone
Number of subjects: 312

Group type: COMPARATOR
Intervention: MRI-targeted biopsy (TBx) plus systematic biopsy (SBx)
Number of subjects: 312
Study: 35395926

Group type: EXPERIMENTAL
Intervention: Puzzle video game training (12 hours over 4 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 0
Study: 33849942

Group type: EXPERIMENTAL
Intervention: Endoscopic full-thickness fundoplication (EFTP)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 70
Study: 32054731

Group type: EXPERIMENTAL
Intervention: Acalabrutinib 100 mg twice daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Acalabrutinib 200 mg once daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acalabrutinib
Number of subjects: 0
Study: 36356331

Group type: COMPARATOR
Intervention: Individual planning condition
Number of subjects: 320

Group type: COMPARATOR
Intervention: Dyadic planning condition
Number of subjects: 320

Group type: COMPARATOR
Intervention: Collaborative planning condition
Number of subjects: 320
Study: 34469056

Group type: EXPERIMENTAL
Intervention: IMRT
Number of subjects: 656

Group type: COMPARATOR
Intervention: 3D-CRT
Number of subjects: 656

Group type: EXPERIMENTAL
Intervention: IMRT subgroup (CI100 ?0.37)
Number of subjects: 656
Study: 35921114

Group type: EXPERIMENTAL
Intervention: 195 mg transdermal cannabidiol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 390 mg transdermal cannabidiol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34967189

Group type: EXPERIMENTAL
Intervention: Cognitive dissonance-based virtual program (two psycho-educative and four cognitive dissonance sessions)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlisted control group
Number of subjects: 0
Study: 34467639

Group type: EXPERIMENTAL
Intervention: Early-food supplementation (daily supplementation starting before 9 gestation weeks)
Number of subjects: 640

Group type: COMPARATOR
Intervention: Usual-food supplementation (daily supplementation starting at 20 gestation weeks)
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: Prenatal supplementation with 30-mg or 60-mg iron with 400-µg folic acid or multiple micronutrients (MM)
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: Early-food and MM groups
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: STAT5b expression
Number of subjects: 640
Study: 33722363

Group type: EXPERIMENTAL
Intervention: 2‐hrClass
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 20‐minVideo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 34643128

Group type: EXPERIMENTAL
Intervention: Healthy checkout lane intervention (moving peanuts to cash registers and upselling)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control condition (no intervention)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Healthy checkout lane intervention with price promotion
Number of subjects: 6
Study: 35292493

Group type: EXPERIMENTAL
Intervention: Early Stroke Specialist Vocational Rehabilitation (ESSVR) plus usual care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 0
Study: 35879008

Group type: EXPERIMENTAL
Intervention: Specialist palliative home care nurse-patient consultation followed by an interprofessional telephone case conference
Number of subjects: 191

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 191
Study: 32464142

Group type: EXPERIMENTAL
Intervention: Etrolizumab
Number of subjects: 535

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 535
Study: 32966563

Group type: COMPARATOR
Intervention: Control condition (natural loading)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: High loading (5% increase in vGRF)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Symmetric loading (vGRF between limbs)
Number of subjects: 30
Study: 35438588

Group type: EXPERIMENTAL
Intervention: Patella-stabilizing, motion-restricting knee brace
Number of subjects: 79

Group type: COMPARATOR
Intervention: Neoprene nonhinged knee brace
Number of subjects: 79
Study: 34610615

Group type: EXPERIMENTAL
Intervention: Midwifery-oriented group counseling based on the GATHER approach (4 sessions of 45 to 90 minutes)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Midwifery-oriented group counseling based on the GATHER approach
Number of subjects: 90
Study: 34927036

Group type: EXPERIMENTAL
Intervention: Bifidobacterium animalis spp. lactis (Bl‐04)
Number of subjects: 334

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 334
Study: 33009977

Group type: EXPERIMENTAL
Intervention: Elemental diet (ELENTAL®) 160 g/day for 9 weeks during chemotherapy
Number of subjects: 71

Group type: COMPARATOR
Intervention: Non-supplementary group (no elemental diet)
Number of subjects: 71
Study: 35074539

Group type: EXPERIMENTAL
Intervention: Preoperative mobilization program
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (no preoperative mobilization program)
Number of subjects: 150
Study: 32631405

Group type: EXPERIMENTAL
Intervention: Vitamin A 25,000 IU daily, Vitamin D 600,000 IU once, Vitamin E 300 IU twice daily, Vitamin C four times per day, B vitamins daily (Soluvit)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no supplements or placebo)
Number of subjects: 60
Study: 33593788

Group type: EXPERIMENTAL
Intervention: Point-of-care viral load testing
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard laboratory viral load monitoring
Number of subjects: 100
Study: 33275112

Group type: EXPERIMENTAL
Intervention: Visual abstract tweets
Number of subjects: 40

Group type: COMPARATOR
Intervention: Citation-only tweets
Number of subjects: 40

Group type: COMPARATOR
Intervention: Key figure tweets
Number of subjects: 40
Study: 33820701

Group type: EXPERIMENTAL
Intervention: Cold-water immersion (CWI) at 13-14 °C for a total of 170 minutes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cold-water immersion (CWI)
Number of subjects: 0
Study: 32100495

Group type: EXPERIMENTAL
Intervention: Suspension moxibustion combined with hormone therapy
Number of subjects: 132

Group type: COMPARATOR
Intervention: Moxibustion
Number of subjects: 132

Group type: COMPARATOR
Intervention: Hormone without moxibustion
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Hormone with moxibustion
Number of subjects: 132
Study: 34687130

Group type: EXPERIMENTAL
Intervention: Nucleotide/nucleoside analogues (NAs)
Number of subjects: 2172

Group type: EXPERIMENTAL
Intervention: High M6-GGT levels (>25 U/L)
Number of subjects: 2172

Group type: EXPERIMENTAL
Intervention: Cirrhosis
Number of subjects: 2172

Group type: EXPERIMENTAL
Intervention: Male sex
Number of subjects: 2172

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 2172

Group type: EXPERIMENTAL
Intervention: High M6-GGT levels (>25 U/L) in non-cirrhotic patients
Number of subjects: 2172

Group type: EXPERIMENTAL
Intervention: High M6-GGT levels in non-cirrhotic patients
Number of subjects: 2172

Group type: EXPERIMENTAL
Intervention: Age in non-cirrhotic patients
Number of subjects: 2172

Group type: EXPERIMENTAL
Intervention: Non-cirrhotic elderly patients with high M6-GGT levels
Number of subjects: 2172
Study: 33631078

Group type: EXPERIMENTAL
Intervention: Zagreb regimen
Number of subjects: 240

Group type: COMPARATOR
Intervention: Essen regimen
Number of subjects: 240
Study: 32572614

Group type: EXPERIMENTAL
Intervention: Calibration group (n=185)
Number of subjects: 351

Group type: COMPARATOR
Intervention: Validation group (n=166)
Number of subjects: 351
Study: 35487727

Group type: EXPERIMENTAL
Intervention: 75 mg alirocumab subcutaneously every 2 weeks for a total of 26 weeks
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (no alirocumab treatment)
Number of subjects: 66
Study: 33851221

Group type: COMPARATOR
Intervention: Folic Acid (FA) supplementation
Number of subjects: 1198
Study: 35911661

Group type: EXPERIMENTAL
Intervention: Distal Radial Access (DRA)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Forearm Radial Access (FRA)
Number of subjects: 209
Study: 35081022

Group type: EXPERIMENTAL
Intervention: High-dose convalescent plasma (CCP) transfusion (3 daily doses of 600 mL/d)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: High-dose convalescent plasma (CCP) transfusion
Number of subjects: 107
Study: 33237632

Group type: EXPERIMENTAL
Intervention: POG patients with WGTA-informed treatment change
Number of subjects: 230

Group type: COMPARATOR
Intervention: POG-naive controls
Number of subjects: 230
Study: 32285460

Group type: EXPERIMENTAL
Intervention: Presence of Perineural invasion (PNI)
Number of subjects: 976
Study: 35436907

Group type: EXPERIMENTAL
Intervention: Group-based training program
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual individual physiotherapy care
Number of subjects: 120
Study: 33764385

Group type: EXPERIMENTAL
Intervention: Experimental treatment (molecular inhibitor)
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Experimental treatment (cytotoxic therapy)
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Experimental treatment (hormone therapy)
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Experimental treatment (immune therapy)
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Primary end point (PFS)
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Overall RCTs
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Reports using a professional medical writer
Number of subjects: 298
Study: 35727083

Group type: EXPERIMENTAL
Intervention: Esketamine (0.5 mg/kg parenteral dose)
Number of subjects: 15
Study: 34949171

Group type: EXPERIMENTAL
Intervention: Proud & Empowered intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 34229074

Group type: EXPERIMENTAL
Intervention: Continuous morphine intravenous infusion
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Simultaneous morphine + naloxone infusion
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo intravenous infusion
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cold‐pressor test (1-4Hz EEG)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Faster EEG (8-12Hz) during cold‐pressor test
Number of subjects: 20
Study: 32385061

Group type: EXPERIMENTAL
Intervention: PIFR-based optimised inhalation therapy and training on inhaler usage at discharge
Number of subjects: 416

Group type: COMPARATOR
Intervention: Control group receiving inhalers based on judgement of the respiratory physician
Number of subjects: 416
Study: 35323052

Group type: EXPERIMENTAL
Intervention: LAMA + LABA (Stiolto Respimat)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 35637984

Group type: EXPERIMENTAL
Intervention: Bipolar radiofrequency ablation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Monopolar radiofrequency ablation
Number of subjects: 50
Study: 32584698

Group type: EXPERIMENTAL
Intervention: TTM at 33°C (TTM33)
Number of subjects: 151

Group type: COMPARATOR
Intervention: TTM at 36°C (TTM36)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Temperature reduction
Number of subjects: 151
Study: 33742764

Group type: EXPERIMENTAL
Intervention: RO6870868 (200–2000 mg)
Number of subjects: 60
Study: 32113916

Group type: COMPARATOR
Intervention: Atazanavir with a glass of water
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Atazanavir with Coca-Cola®
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Atazanavir with water under hypochlorhydric conditions (PPI)
Number of subjects: 5
Study: 35050723

Group type: EXPERIMENTAL
Intervention: Read, Ask, Answer, Prompt (RAAP) intervention taught via telepractice during an initial 60‐min workshop and five advanced practice sessions (M = 28.41 min).
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Read, Ask, Answer, Prompt (RAAP) intervention
Number of subjects: 5
Study: 33393666

Group type: EXPERIMENTAL
Intervention: Narrow Band Imaging (NBI) during flexible endoscopy
Number of subjects: 233

Group type: COMPARATOR
Intervention: White Light Imaging (WLI) during rigid endoscopy
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Narrow Band Imaging (NBI)
Number of subjects: 233
Study: 35673907

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (TCM) + chemotherapy
Number of subjects: 94

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 94
Study: 33556546

Group type: EXPERIMENTAL
Intervention: Mechanical ventilation
Number of subjects: 8296
Study: 32942192

Group type: EXPERIMENTAL
Intervention: Contact intervention for parents with supervised contact, involving increased preparation and support by caseworkers before and after contact visits
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Contact intervention for parents with supervised contact
Number of subjects: 183

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 183
Study: 33400943

Group type: EXPERIMENTAL
Intervention: LY03004
Number of subjects: 100

Group type: COMPARATOR
Intervention: Risperdal Consta®
Number of subjects: 100
Study: 32058431

Group type: EXPERIMENTAL
Intervention: High-definition transcranial direct current stimulation
Number of subjects: 36

Group type: COMPARATOR
Intervention: Bipolar transcranial direct current stimulation
Number of subjects: 36
Study: 33551142

Group type: EXPERIMENTAL
Intervention: Flapless implant placement with immediate functional loading
Number of subjects: 51

Group type: COMPARATOR
Intervention: Flap implant placement with immediate functional loading
Number of subjects: 51
Study: 33960514

Group type: EXPERIMENTAL
Intervention: Individually randomized trials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cluster randomized designs
Number of subjects: 0
Study: 32152738

Group type: EXPERIMENTAL
Intervention: GA+ AB (group receiving ankle block with 100mg lidocaine 2% and 75mg bupivacaine 0.5%)
Number of subjects: 110

Group type: COMPARATOR
Intervention: GA (control group)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: GA+ AB
Number of subjects: 110
Study: 35446296

Group type: EXPERIMENTAL
Intervention: Trauma-focused cognitive behavioral therapy (TF-CBT) for 14 weeks with 2 weeks follow-up
Number of subjects: 74

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 74
Study: 36269661

Group type: EXPERIMENTAL
Intervention: Sodium Hyaluronate plus Polyethylene Glycol (0.15% SH + PEG 8000)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Sodium Hyaluronate (0.18% SH)
Number of subjects: 83
Study: 32253054

Group type: EXPERIMENTAL
Intervention: BGF MDI 320/36/9.6 μg without spacer and no charcoal
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: BGF MDI 320/36/9.6 μg with spacer and no charcoal
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: BGF MDI 320/36/9.6 μg without spacer and with charcoal
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: BGF MDI 320/36/9.6 μg with spacer and with charcoal
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 56
Study: 35841003

Group type: EXPERIMENTAL
Intervention: Conventional fasciotomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lateral fasciotomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patient-reported outcomes at 3 months post-surgery
Number of subjects: 0
Study: 34613402

Group type: EXPERIMENTAL
Intervention: 4F antithrombotic midline catheter (MC-AT)
Number of subjects: 212

Group type: COMPARATOR
Intervention: 4.5F antithrombotic and antimicrobial midline catheter (MC-AT-AM)
Number of subjects: 212
Study: 32956481

Group type: EXPERIMENTAL
Intervention: Superior rectus transposition with or without medial rectus recession
Number of subjects: 20

Group type: COMPARATOR
Intervention: Unilateral medial rectus recession
Number of subjects: 20
Study: 34579074

Group type: EXPERIMENTAL
Intervention: Standardized mixed meal (498 kcal)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Granola bar (260 kcal)
Number of subjects: 14
Study: 32377523

Group type: EXPERIMENTAL
Intervention: No carrageenan diet (n=8)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Carrageenan-containing diet (n=5)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Comparison between no-carrageenan and carrageenan-containing diet groups
Number of subjects: 13
Study: 33727090

Group type: EXPERIMENTAL
Intervention: 8-week RiSE intervention
Number of subjects: 74
Study: 34296980

Group type: EXPERIMENTAL
Intervention: Self-regulatory skills emphasis (n = 47)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Education and self-management (n = 52)
Number of subjects: 99
Study: 34711975

Group type: EXPERIMENTAL
Intervention: Undisclosed self-administration of suboptimal ART
Number of subjects: 2

Group type: COMPARATOR
Intervention: None (control group)
Number of subjects: 2
Study: 35448022

Group type: EXPERIMENTAL
Intervention: Virtual Reality Training Group (VRTG) underwent VR training with BTs‐N
Number of subjects: 100

Group type: COMPARATOR
Intervention: Traditional Cognitive Rehabilitation Group (TCRG) received standard cognitive treatment
Number of subjects: 100
Study: 33128925

Group type: EXPERIMENTAL
Intervention: Normal conditions (NC, 20 °C, RH 60%)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Cold-dry conditions (CC, −20 °C, RH 40%)
Number of subjects: 11
Study: 35145044

Group type: EXPERIMENTAL
Intervention: Pharmacist intervention
Number of subjects: 99
Study: 33811854

Group type: EXPERIMENTAL
Intervention: VETPALS (N=71)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Education control (N=76)
Number of subjects: 147
Study: 32608341

Group type: EXPERIMENTAL
Intervention: Green Dot (GD) bystander intervention training program targeting popular opinion leaders
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Green Dot (GD) participants
Number of subjects: 13

Group type: COMPARATOR
Intervention: Nonparticipants of Green Dot (GD)
Number of subjects: 13
Study: 32967467

Group type: EXPERIMENTAL
Intervention: Gaze Training (GT)
Number of subjects: 17
Study: 32654588

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (14-weeks, four lessons per week)
Number of subjects: 891

Group type: EXPERIMENTAL
Intervention: Cognitively engaging exercise (14-weeks, four lessons per week)
Number of subjects: 891

Group type: COMPARATOR
Intervention: Control group (regular physical education programme)
Number of subjects: 891
Study: 37384576

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 33593749

Group type: EXPERIMENTAL
Intervention: Tofogliflozin 20 mg, orally, once daily for 24 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Pioglitazone 15-30 mg, orally, once daily for 24 weeks
Number of subjects: 40
Study: 32508277

Group type: EXPERIMENTAL
Intervention: Worry Less, Live More: The Mindful Way through Anxiety Workbook
Number of subjects: 64

Group type: COMPARATOR
Intervention: Delayed condition
Number of subjects: 64
Study: 35667714

Group type: EXPERIMENTAL
Intervention: Investigational agents (up to four agents)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control
Number of subjects: 125
Study: 32222958

Group type: EXPERIMENTAL
Intervention: End-to-End (ETE) anastomosis
Number of subjects: 425

Group type: COMPARATOR
Intervention: End-to-Side (ETS) anastomosis
Number of subjects: 425
Study: 34035108

Group type: EXPERIMENTAL
Intervention: Stroke 1-2-0 education programme
Number of subjects: 3200000

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 3200000
Study: 35552930

Group type: EXPERIMENTAL
Intervention: Axillary lymph node dissection (ALND)
Number of subjects: 889

Group type: COMPARATOR
Intervention: Sentinel lymph node biopsy (SLNB) only
Number of subjects: 889
Study: 34555952

Group type: EXPERIMENTAL
Intervention: Supportive nursing interventions
Number of subjects: 85
Study: 34269164

Group type: EXPERIMENTAL
Intervention: DASH diet
Number of subjects: 102

Group type: COMPARATOR
Intervention: Usual dietary advice
Number of subjects: 102
Study: 34516760

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Resilience Training (MBRT)
Number of subjects: 61

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 61
Study: 34579097

Group type: EXPERIMENTAL
Intervention: Calorie restriction (CR)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: CR plus Rope-skipping (CR?RS)
Number of subjects: 46
Study: 32165027

Group type: EXPERIMENTAL
Intervention: Porcine xenograft dressing
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Silver foam dressing
Number of subjects: 58
Study: 34606049

Group type: EXPERIMENTAL
Intervention: Stratified Vocational Advice Intervention (SVAI) delivered by physiotherapists, all sessions conducted by telephone, number of sessions not specified.
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Stratified Vocational Advice Intervention (SVAI)
Number of subjects: 170
Study: 32114088

Group type: EXPERIMENTAL
Intervention: Third person objective narrative voice
Number of subjects: 258

Group type: COMPARATOR
Intervention: Personal narrative voice
Number of subjects: 258

Group type: COMPARATOR
Intervention: Mixed narrative voice
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Sleep blog posts
Number of subjects: 258

Group type: COMPARATOR
Intervention: Vaccine blog posts
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: All narrative voices
Number of subjects: 258
Study: 35978182

Group type: EXPERIMENTAL
Intervention: Scheduled CVC removal after 14 days
Number of subjects: 2984

Group type: EXPERIMENTAL
Intervention: Scheduled CVC removal after 7 days
Number of subjects: 2984

Group type: EXPERIMENTAL
Intervention: Scheduled CVC removal after 21 days
Number of subjects: 2984

Group type: COMPARATOR
Intervention: Unscheduled CVC removal (control group)
Number of subjects: 2984